bluebird bio, Inc. financial data

Symbol
BLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
455 Grand Union Boulevard, Somerville, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Genetix Pharmaceuticals Inc (to 3/19/2010)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 64.6 % -66.3%
Quick Ratio 15.1 % +50.2%
Debt-to-equity 1.33K % +661%
Return On Equity -656 % -576%
Return On Assets -45.8 % -39.9%
Operating Margin -323 % +61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.79M shares
Common Stock, Shares, Outstanding 9.73M shares +0.92%
Entity Public Float 189M USD -45.4%
Common Stock, Value, Issued 1.92M USD +0.95%
Weighted Average Number of Shares Outstanding, Basic 9.69M shares +76.5%
Weighted Average Number of Shares Outstanding, Diluted 9.69M shares +76.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 83.8M USD +184%
Revenue from Contract with Customer, Excluding Assessed Tax 83.8M USD +188%
Cost of Revenue 89.4M USD +167%
Research and Development Expense 94.3M USD -43.8%
Costs and Expenses 265M USD -20.5%
Operating Income (Loss) -270M USD -10.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91.1M USD +78.9%
Income Tax Expense (Benefit) 70K USD
Net Income (Loss) Attributable to Parent -241M USD -13.6%
Earnings Per Share, Basic -24.8 USD/shares +35.6%
Earnings Per Share, Diluted -24.8 USD/shares +35.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 62.3M USD -71.9%
Marketable Securities, Current 0 USD -100%
Inventory, Net 65M USD +184%
Other Assets, Current 17.4M USD
Assets, Current 155M USD -45.1%
Property, Plant and Equipment, Net 62.6M USD +528%
Operating Lease, Right-of-Use Asset 177M USD -12%
Intangible Assets, Net (Excluding Goodwill) 9.55M USD -8.54%
Goodwill 5.65M USD 0%
Other Assets, Noncurrent 52.6M USD -3.13%
Assets 460M USD -25.7%
Accounts Payable, Current 34.3M USD +85.5%
Employee-related Liabilities, Current 14.4M USD -27.7%
Contract with Customer, Liability, Current 9.65M USD +517%
Liabilities, Current 321M USD +60.6%
Operating Lease, Liability, Noncurrent 162M USD -13.5%
Other Liabilities, Noncurrent 947K USD +929%
Liabilities 492M USD +15.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.13M USD -18.8%
Retained Earnings (Accumulated Deficit) -4.5B USD -5.65%
Stockholders' Equity Attributable to Parent -31.5M USD -116%
Liabilities and Equity 460M USD -25.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -74.7M USD -4.65%
Net Cash Provided by (Used in) Financing Activities 64.6M USD -43.9%
Net Cash Provided by (Used in) Investing Activities -655K USD -101%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 9.73M shares +0.92%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 106M USD -61.4%
Deferred Tax Assets, Valuation Allowance 1.24B USD +4.04%
Deferred Tax Assets, Gross 1.3B USD +2.93%
Operating Lease, Liability 187M USD -10.2%
Payments to Acquire Property, Plant, and Equipment 1.78M USD +665%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -241M USD -15%
Lessee, Operating Lease, Liability, to be Paid 229M USD -13.2%
Property, Plant and Equipment, Gross 27.1M USD -22.9%
Operating Lease, Liability, Current 25.1M USD +18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 35.7M USD -3.68%
Lessee, Operating Lease, Liability, to be Paid, Year One 37.1M USD +6.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.6M USD -24.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 36.7M USD +2.86%
Deferred Tax Assets, Operating Loss Carryforwards 781M USD +7.58%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 24.5M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 37.8M USD +2.87%
Operating Lease, Payments 2.84M USD -55.3%
Additional Paid in Capital 4.47B USD +0.34%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 13.7M USD -29.3%
Interest Expense 16.9M USD +13.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%